CRP and Sepsis: A recent published meta-analysis indicated that compared with conventional therapies, XBJ as adjunctive therapy for sepsis could significantly decrease APACHE II score, 28-day mortality, temperature, and serum levels of PCT, WBC, CRP, and NEU (Shi et al., 2017).